Shelly Parpart got a second opinion after she was diagnosed with pancreatic cancer. The 37-year-old mother returned to Beaumont because it offered more cancer treatment options, including an experimental vaccine, the first new option to treat pancreatic cancer in 30 years.
The vaccine is a welcome development because pancreatic tumors are the fourth leading cause of cancer death in the United States, with a survival time averaging 18-24 months. The disease appears in women and men about equally.
- Beaumont’s Minority Outreach Program Offers Early-Detection Screenings for Hundreds
- Runner Competes in Marathon 3 Weeks After Robotic Prostate Surgery
- ‘Stars Guitars’ Auction and Concert Benefits Kids After Cancer
- Beaumont Seeking Volunteers for Colon Cancer Prevention Study
- Beaumont Leads National Trial Studying Shorter Radiation Treatment for Breast Cancer
- Beaumont is First in Southeast Michigan to Offer Molecular Imaging to Detect Breast Cancer
- Beaumont Unveils New Nanoknife Technology to Treat Cancer